Arkolith/Insider Trading/CRBP/Form 4

Altmeyer Anne

DirectorCorbus Pharmaceuticals Holdings, Inc. (CRBP) · full profile →Form 4 · filed Oct 21, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$22K
Net Open-Market Flow
-$22K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 20, 2025Option exercise(M)1K$4.80$5K7K
Oct 20, 2025Sell(S)1K$20.50$22K6K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Oct 20, 2025Option exercise(M)1K—$04K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-25-245262) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for Corbus Pharmaceuticals Holdings, Inc.

Build

Ask your agent about CRBP insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001193125-25-245262"
Ask your agent
Use Arkolith to summarize insider buying and selling at Corbus Pharmaceuticals Holdings, Inc.
over the last 90 days and cite the filings.